Tenon Medical Regains Nasdaq Minimum Bid Price Compliance

What Happened Tenon Medical, Inc. announced on August 24, 2026 that the Listing Qualifications staff of The Nasdaq Stock Market LLC has confirmed the company has regained compliance with Nasdaq’s minimum bid price requirement under Rule 5550(a)(2). Nasdaq’s notice states that this compliance matter is closed. Tenon furnished a press release about the development as Exhibit 99.1 to the Form 8-K.

Key Details

• Date of notice and filing: August 24, 2026.
• Nasdaq rule referenced: Listing Rule 5550(a)(2) — the minimum $1.00 per share bid price requirement.
• Outcome: Nasdaq confirmed regained compliance and the matter is closed.
• Company action: Press release announcing the Nasdaq confirmation was furnished with the 8-K.

Why It Matters Regaining compliance with Nasdaq’s minimum bid price requirement removes the immediate listing deficiency that could have led to delisting proceedings, preserving the company’s Nasdaq listing. For investors, maintaining the exchange listing supports continued visibility and trading liquidity for Tenon Medical shares and reduces regulatory uncertainty tied to the prior deficiency.